Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 1,893 shares at $331.46 ($610K) on 2021-01-29, disclosed to the SEC on 2021-02-02.
Open-market sale of $610k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $318.48 | 300 | $96K | 15.7% |
| 2 | $319.61 | 393 | $126K | 20.6% |
| 3 | $319.61 | 393 | $126K | 20.6% |
| 4 | $320.81 | 7 | $2K | 0.4% |
| 5 | $322.51 | 300 | $97K | 15.9% |
| 6 | $323.85 | 100 |
| $32K |
| 5.3% |
| 7 | $326.58 | 100 | $33K | 5.4% |
| 8 | $330.05 | 100 | $33K | 5.4% |
| 9 | $331.46 | 200 | $66K | 10.9% |
| Total | $322.29 avg | 1,893 | $610K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |